Future Planet Capital

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Kallik is a global provider of labeling content management and artwork generation solutions tailored for regulated industries, including pharmaceuticals, medical devices, cosmetics, chemicals, and food and beverage. The company develops enterprise software that enables manufacturers to centralize messaging content and produce print-ready artwork for packaging and labeling. By streamlining labeling processes, Kallik helps clients maintain compliance and enhance efficiency in their operations, ensuring that they meet the stringent requirements of their respective markets.

Steel Seal manufactures a specialized chemical compound mixture designed to create a hardened seal in damaged areas of head gaskets or blocks. The product reacts under heat and pressure, forming a repair seal for blown steel and aluminum head gaskets, helping customers avoid costly replacements.

Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

Kallik is a global provider of labeling content management and artwork generation solutions tailored for regulated industries, including pharmaceuticals, medical devices, cosmetics, chemicals, and food and beverage. The company develops enterprise software that enables manufacturers to centralize messaging content and produce print-ready artwork for packaging and labeling. By streamlining labeling processes, Kallik helps clients maintain compliance and enhance efficiency in their operations, ensuring that they meet the stringent requirements of their respective markets.

Oxford Advanced Surfaces Group Plc is a company that focuses on surface modification. When it comes to surface modification, we are the experts. As a team we have over 70 years of experience and over 30 patents in this field since our commercialisation out of the University of Oxford. Our team of scientists is highly skilled in the synthesis and formulation of Onto™ materials, so we design and optimise products to meet the needs of real industrial challenges.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Oxford Advanced Surfaces Group Plc is a company that focuses on surface modification. When it comes to surface modification, we are the experts. As a team we have over 70 years of experience and over 30 patents in this field since our commercialisation out of the University of Oxford. Our team of scientists is highly skilled in the synthesis and formulation of Onto™ materials, so we design and optimise products to meet the needs of real industrial challenges.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

Kallik is a global provider of labeling content management and artwork generation solutions tailored for regulated industries, including pharmaceuticals, medical devices, cosmetics, chemicals, and food and beverage. The company develops enterprise software that enables manufacturers to centralize messaging content and produce print-ready artwork for packaging and labeling. By streamlining labeling processes, Kallik helps clients maintain compliance and enhance efficiency in their operations, ensuring that they meet the stringent requirements of their respective markets.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

Kallik is a global provider of labeling content management and artwork generation solutions tailored for regulated industries, including pharmaceuticals, medical devices, cosmetics, chemicals, and food and beverage. The company develops enterprise software that enables manufacturers to centralize messaging content and produce print-ready artwork for packaging and labeling. By streamlining labeling processes, Kallik helps clients maintain compliance and enhance efficiency in their operations, ensuring that they meet the stringent requirements of their respective markets.